Skip Nav Destination
1-7 of 7
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single- chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor
DA Vallera, A Panoskaltsis-Mortari, C Jost, S Ramakrishnan, CR Eide, RJ Kreitman, PJ Nicholls, C Pennell, BR Blazar
Blood (1996) 88 (6): 2342–2353.
Reactivity of murine cytokine fusion toxin, diphtheria toxin390-murine interleukin-3 (DT390-mIL-3), with bone marrow progenitor cells
Blood (1996) 88 (4): 1445–1456.
Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR)
Blood (1996) 87 (10): 4333–4339.
A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells
Blood (1995) 86 (7): 2732–2740.
Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma
Blood (1994) 83 (2): 426–434.
Recombinant toxins containing the variable domains of the anti-Tac monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia
Blood (1992) 80 (9): 2344–2352.
Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma
Blood (1992) 79 (7): 1775–1780.